MedTrace Logo

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

NCT00816075 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-02-17

No results posted yet for this study

Summary

The purpose of this study is to compare and evaluate the efficacy of distilled water vs Mitomycin C on preventing the recurrences of intermediate risk group recurrent superficial bladder cancer administered as a single dose immediate instillation after complete Transurethral Resection(TUR) of the tumor.

Conditions

  • Recurrent Superficial Bladder Cancer
  • Distilled Water

Interventions

DRUG

distilled water

we plan to administer 200ml of distilled water after TUR of the tumor and block the catheter for 2 hours

Sponsors & Collaborators

  • Bozyaka Training and Research Hospital

    lead OTHER

Principal Investigators

  • Zafer Kozacioglu, MD · Bozyaka Trainig and Research Hospital Urology Clinic

  • Murat Arslan, MD · Bozyaka Training and Research Hospital Urology Clinic

  • Tansu Degirmenci, MD · Bozyaka Training and Research Hospital Urology Clinic

  • Fatih Duz, MD · Bozyaka Training and Research Hospital Urology Clinic

  • Ali R Ayder, MD · Bozyaka Training and Research Hospital Urology Clinic

  • Nukhet Eliyatkin, MD · Bozyaka Training and Research Hospital Pathology Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-01-31
Completion
2011-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816075 on ClinicalTrials.gov